DES

Nuevo dispositivo para tener mayor protección en la angioplastia carotídea

Carotid Stenosis and TAVR

Aortic Stenosis affects over 5% of the population over 65.  Even though TAVR has advanced in the treatment of this disease, many patients present carotid aortic stenosis (CAS), which involves additional surgical risk. This risk has not been thoroughly assessed in the context of TAVR.  A meta-analysis was carried out including 5 observational studies with...

Intervención tricuspídea heterotópica: Resultados de TricValve a un año

ACURATE Neo2: One-Year Hemodynamic and Clinical Benefit Results

Both Acurate Neo2 and its predecessor, Acurate Neo, have proven their safety and efficacy in the percutaneous treatment of severe aortic stenosis. The Acurate platform offers a lower gradient and a larger effective orifice area, as well as a low risk of periprocedural complications, according to previous registries.  However, the first-generation Acurate device had some...

¿Son las válvulas autoexpandibles una opción válida en las bicúspides?

Evolution of Bicuspid Valves at 12 Months

Severe aortic stenosis due to a bicuspid aortic valve (BAV) is uncommon, especially in individuals under 65 years of age. While there are usually no significant differences according to the type of valve when it comes to surgery, with transcatheter aortic valve replacement (TAVR) some may arise.  TAVR has seen significant advancements in the treatment...

Sistema EVOQUE: reemplazo tricuspídeo transcatéter, resultados al año

TAVR: High Implantation of Self-Expanding Valves Directly Impacts ECG

TAVR has been shown beneficial, especially in high risk or inoperable patients. However, there are limitations to its use, especially with self-expanding valves, which are the need for pacemaker implantation and ECG changes after procedure.  To address this matter, researchers assessed the right and left cusp overlap effect on 254 patients undergoing TAVR with self-expanding...

¿Es frecuente el uso de IVUS para guiar la ATC?

Use of IVUS in Complex PCI: Results according to Operator Experience

The use of ultravascular ultrasound (IVUS) to guide coronary angioplasty procedures (PCI) has been shown to reduce the risk of major adverse events in numerous randomized controlled studies, registries and meta-analysis.  The current guidelines recommend the use of IVUS in left main disease and complex lesions. The proportion of complex PCI procedures has increased over...

Miami Valves 2024 - Descuento SOLACI

Miami Valves 2024: 35% Discount for SOLACI Members!

From February 1 to 3, 2024, Miami Valves 2024 will be held in Miami, Florida, US, at the Miami Marriot Byscayne Bay Hotel. This event has been founded by faculty members of Miami University centers of excellence and complemented by key opinion leaders from around the world; here you will be able to attend powerful lectures and...

Outcomes of the Use of Drug Coated Balloons in the Treatment of De Novo Coronary Lesions

Drug coated balloon (DCB) angioplasty offers a novel strategy for treating coronary artery disease. Studies assessing this strategy have shown clinical outcomes comparable to drug-eluting stents’ (DES) in patients with in-stent restenosis and de novo disease in small vessels. However, evidence for the use of DCB in large coronary vessels is limited. This observational, retrospective study DCB...

See the Presentations of the 2023 Perú Sessions

The XLVII SOLACI Regional Sessions – 16th Andean Region took place in Lima, Peru, between November 16 and 17, 2023.It was an extremely successful event that featured the participation of prestigious national and international guests and a high-level scientific program. Below, we share some of the presentations that were made during the Sessions. Dra. Carla...

Top